Convergent and criterion validity of the CogState computerized brief battery cognitive assessment in women with and without breast cancer
- PMID: 28080264
- PMCID: PMC5507751
- DOI: 10.1080/13854046.2016.1275819
Convergent and criterion validity of the CogState computerized brief battery cognitive assessment in women with and without breast cancer
Abstract
Objective: Computerized tests have increasingly garnered interest for assessing cognitive functioning due to their potential logistical and financial advantages over traditional 'pencil and-paper' neuropsychological tests. However, psychometric information is necessary to guide decisions about their clinical and research utility with varied populations. We explored the convergent construct validity and criterion validity of the CogState computerized tests in breast cancer survivors, a group known to present with mostly mild, subtle cognitive dysfunction.
Method: Fifty-three post-menopausal women (26 breast cancer survivors, 27 healthy controls) completed the CogState Brief Battery tests with passed performance checks, conceptually matched traditional neuropsychological tests, and a self-report measure of daily functioning, the Functional Activities Questionnaire.
Results: Significant positive correlations were found between the CogState Brief Battery tests and traditional neuropsychological tests, although the traditional tests specifically hypothesized to correlate with CogState tests did not reach statistical significance. Analysis of Covariance results showed preliminary support for criterion validity, as the patient and control groups differed on the traditional test of working memory (Digits Backwards, p = .01), with a trend towards significance for the CogState test of working memory (One Back, p = .02), controlled for age, race, and mood.
Conclusions: The results provide preliminary support for further research to determine if the CogState tests are viable as screening tools to detect subtle cognitive differences between breast cancer survivors and healthy women. Our study was limited by the low base rate of cognitive impairment and small sample size. We recommend further research employing sufficiently powered sample sizes and a longitudinal, repeated measures study design.
Keywords: CogState; Neurocognitive testing; breast cancer; computerized cognitive testing; validity.
Conflict of interest statement
Conflict of Interest Statement: The authors have no financial disclosures for this manuscript.
Similar articles
-
Reliability and validity of the CogState computerized battery in patients with seizure disorders and healthy young adults: comparison with standard neuropsychological tests.Clin Neuropsychol. 2017 Apr;31(3):569-586. doi: 10.1080/13854046.2016.1256435. Epub 2016 Nov 17. Clin Neuropsychol. 2017. PMID: 27852143
-
Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.J Clin Exp Neuropsychol. 2017 Oct;39(8):753-767. doi: 10.1080/13803395.2016.1263282. Epub 2017 Jan 4. J Clin Exp Neuropsychol. 2017. PMID: 28052738
-
Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex.Arch Clin Neuropsychol. 2009 Mar;24(2):165-78. doi: 10.1093/arclin/acp010. Epub 2009 Mar 25. Arch Clin Neuropsychol. 2009. PMID: 19395350
-
A review of the validity of computerized neurocognitive assessment tools in mild traumatic brain injury assessment.Concussion. 2017 Jan 30;2(1):CNC31. doi: 10.2217/cnc-2016-0021. eCollection 2017 Mar. Concussion. 2017. PMID: 30202572 Free PMC article. Review.
-
Computerized neuropsychological assessment devices in multiple sclerosis: A systematic review.Mult Scler. 2019 Dec;25(14):1848-1869. doi: 10.1177/1352458519879094. Epub 2019 Oct 22. Mult Scler. 2019. PMID: 31637963 Free PMC article.
Cited by
-
Novel computerized neurocognitive test battery is sensitive to cancer-related cognitive deficits in survivors.J Cancer Surviv. 2024 Apr;18(2):466-478. doi: 10.1007/s11764-022-01232-w. Epub 2022 Aug 8. J Cancer Surviv. 2024. PMID: 35939254 Free PMC article.
-
Assessment of cerebral oxygenation response to hemodialysis using near-infrared spectroscopy (NIRS): Challenges and solutions.J Innov Opt Health Sci. 2021 Nov;14(6):2150016. doi: 10.1142/s1793545821500164. Epub 2021 Jun 17. J Innov Opt Health Sci. 2021. PMID: 35173820 Free PMC article.
-
Cognitive impairments associated with chemotherapy in women with breast cancer: a meta-analysis and meta-regression.Braz J Med Biol Res. 2023 Oct 13;56:e12947. doi: 10.1590/1414-431X2023e12947. eCollection 2023. Braz J Med Biol Res. 2023. PMID: 37851791 Free PMC article.
-
The Real-World Usability, Feasibility, and Performance Distributions of Deploying a Digital Toolbox of Computerized Assessments to Remotely Evaluate Brain Health: Development and Usability Study.JMIR Form Res. 2024 May 13;8:e53623. doi: 10.2196/53623. JMIR Form Res. 2024. PMID: 38739916 Free PMC article.
-
Effects of a multicomponent resistance-based exercise program with protein, vitamin D and calcium supplementation on cognition in men with prostate cancer treated with ADT: secondary analysis of a 12-month randomised controlled trial.BMJ Open. 2022 Jun 24;12(6):e060189. doi: 10.1136/bmjopen-2021-060189. BMJ Open. 2022. PMID: 35750461 Free PMC article. Clinical Trial.
References
-
- Brandt J, Benedict HB. The Hopkins Verbal Learning Test-Revised: Professional Manual. Lutz, FL: Psychological Assessment Resources; 2001.
-
- CogState Limited. CogState research manual version 6. Melbourne, Australia: 2011.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical